Validation of Neurokeeper's Algorithm on Patients Undergoing Carotid Endarterectomy
1 other identifier
observational
N/A
1 country
1
Brief Summary
The primary objective of the study is to validate an EEG base algorithm system to detect and monitor changes in cerebral electrophysiological parameters as compared to clinical evaluation in patients undergoing Carotid Endarterectomy. The secondary objectives is measure time from ICA clamping to algorithm asymmetry detection, time from clinical deterioration to algorithm asymmetry detection Thi study is a prospective, open label, single arm, self control, single center study. This study will be conducted in 50 subjects according to the inclusions/exclusions criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2012
CompletedFirst Posted
Study publicly available on registry
November 29, 2012
CompletedStudy Start
First participant enrolled
June 1, 2013
CompletedJuly 18, 2013
July 1, 2013
November 27, 2012
July 17, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neurological detrioration detection
The primary objective of the study is to validate an EEG base algorithm system to detect and monitor changes in cerebral electrophysiological parameters as compared to clinical evaluation in patients undergoing Carotid Endarterectomy.
Secondary Outcomes (1)
Time from deterioration to detection
Study Arms (1)
Patients undergoing cartoid endarterectomy surgery
Interventions
Electrophisoloigcal monitoring
Eligibility Criteria
Patients undergoing Carotid Endarterectomy
You may qualify if:
- Age \> 18 years old.
- Primary Carotid Endarterectomy under local anesthesia in symptomatic or asymptomatic patients.
You may not qualify if:
- General anesthesia
- Selective carotid artery shunting.
- Previous major hemispheric stroke.
- Any known major hemispheric lesion.
- Significant movement disorder.
- Local skull or skin affliction which prevents electrodes application.
- Any known condition which in the opinion of the investigator may interfere with the protocol implementation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rambam Medical Center
Haifa, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moshe' Herskovitz, MD
Rambam Health Care Campus
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2012
First Posted
November 29, 2012
Study Start
June 1, 2013
Last Updated
July 18, 2013
Record last verified: 2013-07